Hyundai Pharmaceutical Co., Ltd. (KRX:004310)

South Korea flag South Korea · Delayed Price · Currency is KRW
3,235.00
+5.00 (0.15%)
At close: Mar 24, 2025, 3:30 PM KST
-17.89%
Market Cap 89.54B
Revenue (ttm) 108.14B
Net Income (ttm) 1.41B
Shares Out 27.68M
EPS (ttm) 60.34
PE Ratio 53.61
Forward PE n/a
Dividend 30.00 (0.93%)
Ex-Dividend Date Mar 4, 2025
Volume 16,192
Average Volume 51,989
Open 3,215.00
Previous Close 3,230.00
Day's Range 3,205.00 - 3,270.00
52-Week Range 3,135.00 - 6,620.00
Beta 0.54
RSI 36.12
Earnings Date n/a

About Hyundai Pharmaceutical

Hyundai Pharmaceutical Co., Ltd. manufactures and distributes pharmaceutical products, health food drinks, and medical devices in South Korea and internationally. The company offers a range of ETC and OTC products in various therapeutic areas, including antianginal, antibiotic, antiemetics+antinauseants, antihistamines and antiallergics, antihyperlipidemic, antihypertensive, antiplatelet agent, antitussives, cell stimulants and proliferants, central nervous system, depilatory, dermatological agent, dermatology, dietary supplements, digestive sy... [Read more]

Sector Healthcare
Founded 1965
Employees 393
Stock Exchange Korea Stock Exchange
Ticker Symbol 004310
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.